Pseudohypoparathyroidism type Ia. Albright hereditary osteodystrophy: A model for research on G protein-coupled receptors and genomic imprinting

Netherlands Journal of Medicine

Volumn 56, Issue 3, 2000, Pages 100-109

  Simon, A ^a   Koppeschaar, H P F ^a   Roijers, J F M ^a   Hoppener J W M ^a   Lips, C J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Albright hereditary osteodystrophy; G(s) mutation; Haploinsufficiency

Indexed keywords

CALCITRIOL; CALCIUM; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; VITAMIN D DERIVATIVE;

ALBRIGHT SYNDROME; BONE DEMINERALIZATION; GENOME IMPRINTING; HORMONE RESISTANCE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; HYPERPHOSPHATEMIA; HYPOCALCEMIA; MUTATION; PHENOTYPE; PSEUDOHYPOPARATHYROIDISM; REVIEW; SIGNAL TRANSDUCTION;

CALCIUM; FIBROUS DYSPLASIA, POLYOSTOTIC; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; MUTATION; PSEUDOHYPOPARATHYROIDISM; SIGNAL TRANSDUCTION;

EID: 0034159984     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(99)00130-8     Document Type: Review

References (69)

1. Albright F., Burnett C.H., Smith P.H., Parson W. Pseudo-hypoparathyroidism - an example of `Seabright-Bantam syndrome'. Endocrinology. 30:1942;922-932.
2. Farfel Z., Bourne H.R., Iiri T. The expanding spectrum of G protein diseases. New Engl J Med. 340:1999;1012-1020.
3. Strader C.D., Ming Fong T., Tota M.R., Underwood D., Dixon R.A.F. Structure and function of G protein-coupled receptors. Annu Rev Biochem. 63:1994;101-132.
4. Neer E.J. Heterotrimeric G proteins: organizers of transmembrane signals. Cell. 80:1995;249-257.
5. Levine M.A., Downs R.W. Jr., Singer M., Marx S.J., Aurbach G.D., Spiegel A.M. Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism. Biochem Biophys Res Commun. 94:1980;1319-1324.
6. Farfel Z., Brickman A.S., Kaslow H.R., Brothers V.M., Bourne H.R. Defect of receptor-cyclase coupling protein in pseudohypoparathyroidism. New Engl J Med. 303:1980;237-242.
7. Farfel Z., Bourne H.R. Deficient activity of receptor-cyclase coupling protein in platelets of patients with pseudohypoparathyroidism. J Clin Endocrinol Metab. 51:1980;1202-1204.
8. Levine M.A., Eil C., Downs R.W. Jr., Spiegel A.M. Deficient guanine nucleotide regulatory unit activity in cultured fibroblast membranes from patients with pseudohypopara-thyroidism type I: a cause of impaired synthesis of cAMP by intact and broken cells. J Clin Invest. 72:1983;316-324.
9. Farfel Z., Abood M.E., Brickman A.S., Bourne H.R. Deficient activity of receptor-cyclase coupling protein in transformed lymphoblasts of patients with pseudohypoparathyroidism type I. J Clin Endocrinol Metab. 55:1982;113-117.
10. Downs R.W. Jr., Levine M.A., Drezner M.K., Burch W.M. Jr., Spiegel A.M. Deficient adenylate cyclase regulatory protein in renal membranes from a patient with pseudohypoparathyroidism. J Clin Invest. 71:1983;231-235.
11. Ong O.C., Van Dop C., Fung B.K.K. Real-time monitoring of reduced β-adrenergic response in fibroblasts from patients with pseudohypoparathyroidism. Anal Biochem. 238:1996;76-81.
12. Downs R.W., Sekura R.D., Levine M.A., Spiegel A.M. The inhibitory adenylate cyclase coupling protein in pseudohypoparathyroidism. J Clin Endocrinol Metab. 61:1985;351-354.
13. Akita Y., Saito T., Yajima Y., Sakuma S. The stimulatory and inhibitory guanine nucleotide-binding proteins of adenylate cyclase in erythrocytes from patients with pseudohypoparathyroidism type I. J Clin Endocrinol Metab. 61:1985;1012-1017.
14. s as the molecular basis for Albright Hereditary Osteodystrophy. Proc Natl Acad Sci USA. 85:1988;617-621.
15. Levine M.A., Spiegel A.M. Pseudohypoparathyroidism. DeGroot L.J., Besser M., Burger H.G., et al. Endocrinology. 3rd ed. 1995;1136-1150 WB Saunders, Philadelphia.
16. Davies S.J., Hughes H.E. Imprinting in Albright's hereditary osteodystrophy. J Med Genet. 30:1993;101-103.
17. Stogmann W., Fischer J.A. Pseudohypoparathyroidism: disappearance of the resistance to parathyroid extract during treatment with vitamin D. Am J Med. 59:1975;140-144.
18. Kidd G.S., Schaaf M., Adler R.A., Lassman M.N., Wray H.L. Skeletal responsiveness in pseudohypoparathyroidism: a spectrum of clinical disease. Am J Med. 68:1980;772-781.
19. Burnstein M.I., Kottamasu S.R., Pettifor J.M., et al. Metabolic bone disease in pseudohypoparathyroidism: radiologic features. Radiology. 155:1985;351-356.
20. Murray T.M., Rao L.G., Wong M.M., et al. Pseudohypoparathyroidism with osteitis fibrosa cystica: direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone. J Bone Miner Res. 8:1993;83-91.
21. Ishshalom S., Rao L.G., Levine M.A., et al. Normal parathyroid hormone responsiveness of bone-derived cells from a patient with pseudohypoparathyroidism. J Bone Miner Res. 11:1996;8-14.
22. Brown M.D., Aarons G. Pseudohypoparathyroidism: a case report. Pediatr Dentistry. 13:1991;106-109.
23. Levine M.A., Jap T.S., Hung W. Infantile hypothyroidism in two sibs: an unusual presentation of pseudohypoparathyroidism Ia. J Pediatr. 107:1985;919-922.
24. Shima M., Nose O., Shimizu K., Seino Y., Yabuuchi H., Saito T. Multiple associated endocrine abnormalities in a patient with pseudohypoparathyroidism type Ia. Eur J Pediatr. 147:1988;536-538.
25. Namnoum A.B., Merriam G.R., Moses A.M., Levine M.A. Reproductive dysfunction in women with Albright's hereditary osteodystrophy. J Clin Endocrinol Metab. 83:1998;824-829.
26. sα in patients with gain and loss of endocrine function. Nature. 371:1994;164-167.
27. Brickman A.S., Carlson H.E., Levin S.R. Responses to glucagon infusion in PHP. J Clin Endocrinol Metab. 63:1986;1354-1360.
28. Levine M.A., Downs R.W. Jr., Moses A.M., et al. Resistance to multiple hormones in patients with PHP: association with deficient activity of guanine nucleotide regulatory protein. Am J Med. 74:1983;545-556.
29. Shapiro M.S., Bernheim J., Gutman A., Arber I., Spitz I.M. Multiple abnormalities of anterior pituitary hormone secretion in association with PHP. J Clin Endocrinol Metab. 51:1980;483-487.
30. Moses A.M., Weinstock R.S., Levine M.A., Breslau N.A. Evidence for normal antidiuretic responses to endogenous and exogenous arginine vasopressin in patients with guanine nucleotide-binding stimulatory protein-deficient PHP. J Clin Endocrinol Metab. 62:1986;221-224.
31. Ridderskamp P., Schlaghecke R. Pseudohypoparathyreoidismus und Nebennierrinden-insuffizienz. Klin Wochenschr. 68:1990;927-931.
32. Brickman A.S., Weitzman R.E. Renal resistance to arginine vasopressin in PHP. Clin Res. 26:1978;164A. (Abstract).
33. Faull C.M., Welbury R.R., Paul B., Kendall-Taylor P. Pseudohypoparathyroidism: its phenotypic variability and associated disorders in a large family. Q J Med. 78:1991;251-264.
34. Scott D.C., Hung W. Pseudohypoparathyroidism type Ia and growth hormone deficiency in two siblings. J Pediatr Endocrinol Metab. 8:1995;205-207.
35. Manfredi R., Zucchini A., Azzaroli L., Manfredi G. Pseudopseudohypoparathyroidism associated with idiopathic growth hormone deficiency. Role of treatment with biosynthetic growth hormone. J Endocrinol Invest. 16:1993;709-713.
36. Stirling H.F., Barr D.G.D., Kelnar C.J.H. Familial growth hormone-releasing hormone deficiency in pseudopseudohypoparathyroidism. Arch Dis Child. 66:1991;533-535.
37. Fitch N. Albright's hereditary osteodystrophy: a review. Am J Med Genet. 11:1982;11-29.
38. Trüeb R.M., Panizzon R.G., Burg G. Cutaneous ossification in Albright's hereditary osteodystrophy. Dermatology. 186:1993;205-209.
39. Eyre W.G., Reed W.B. Albright's hereditary osteodystrophy with cutaneous bone formation. Arch Dermatol. 104:1971;634-642.
40. Poznanski A.K., Werder E.A., Giedion A. The pattern of shortening of the bone of the hand in PHP and PPHP: a comparison with brachydactyly E, Turner syndrome, and acrodystosis. Radiology. 123:1977;707-718.
41. Steinbach H.I., Rudhe U., Jonsson M., Young D.A. Evolution of skeletal lesions in pseudohypoparathyroidism. Radiology. 85:1965;670-676.
42. Karaplis A.C., Luz A., Glowacki J., et al. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev. 8:1994;277-289.
43. Amizuka N., Warshawsky H., Henderson J.E., Goltzman D., Karaplis A.C. Parathyroid hormone-related peptide depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J Cell Biol. 126:1994;1611-1623.
44. Amizuka N., Karaplis A.C., Henderson J.E., et al. Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Dev Biol. 175:1996;166-176.
45. Mallette L.E., Kirkland J.L., Gagel R.F., Law W.M. Jr., Heath H. Synthetic human parathyroid hormone-(1-34) for the study of pseudohypoparathyroidism. J Clin Endocrinol Metab. 67:1988;964-972.
46. Kruse K., Kracht U., Wohlfart K., Kruse U. Biochemical markers of bone turnover, intact serum parathyroid hormone and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment. Eur J Pediatr. 148:1989;535-539.
47. sα gene. Proc Natl Acad Sci USA. 85:1988;2081-2085.
48. sα (GNAS1), the probable candidate gene for Albright hereditary osteodystrophy, is assigned to human chromosome 20q12-q13.2. Genomics. 10:1991;257-261.
49. Levine M.A., Modi W.S., O'Brien S.J. Mapping of the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase (GNAS1) to 20q13.2-13.3 in human by in situ hybridization. Genomics. 11:1991;478-479.
50. Patten J.L., Johns D.R., Valle D., et al. Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. New Engl J Med. 322:1990;1412-1419.
51. sα-subunit gene in Albright hereditary osteodystrophy detected by denaturing gel electrophoresis. Proc Natl Acad Sci USA. 87:1990;8287-8290.
52. sα gene (GNAS1) in a patient with Albright hereditary osteodystrophy. Genomics. 13:1992;1319-1321.
53. s protein mutation and Albright hereditary osteodystrophy. Clin Res. 40:1992;95A. (abstract).
54. Miric A., Vechio J.D., Levine M.A. Heterogeneous mutations in the gene encoding the α-subunit of the stimulatory G protein of adenylyl cyclase in Albright hereditary osteodystrophy. J Clin Endocrinol Metab. 76:1993;1560-1568.
55. sα gene (GNAS1) in Albright hereditary osteodystrophy. Genomics. 21:1994;455-457.
56. sα mutant in a patient with Albright hereditary osteodystrophy uncouples cell surface receptors from adenylyl cyclase. J Biol Chem. 269:1994;25387-25391.
57. sα gene mutations in Albright hereditary osteodystrophy. J Med Genet. 31:1994;835-839.
58. s alpha gene. Hum Genet. 97:1996;73-75.
59. sα gene in a Japanese patient with pseudohypoparathyroidism. J Endocrinol Invest. 19:1996;236-241.
60. s in patients with pseudohypoparathyroidism type Ia. J Bone Miner Res. 5:1990;S142. (abstract).
61. sα impairs receptor stimulation. J Biol Chem. 271:1996;19653-19655.
62. sα in a patient with pseudohypoparathyroidism. Mol Endocrinol. 11:1997;1718-1727.
63. Ahmed S.F., Dixon P.H., Bonthron D.T., et al. GNAS1 mutational analysis in pseudohypoparathyroidism. Clin Endocrinol. 49:1998;525-531.
64. s in pseudo- and pseudopseudohypoparathyroidism. J Clin Endocrinol Metab. 83:1998;935-938.
65. sα gene (GNAS1) in Albright hereditary osteodystrophy. J Clin Endocrinol Metab. 84:1999;3254-3259.
66. Campbell R., Gosden C.M., Bonthron D.T. Parental origin of transcription from the human GNAS1 gene. J Med Genet. 31:1994;607-614.
67. Ringel M.D., Schwindinger W.F., Levine M.A. Clinical implications of genetic defects in G proteins: the molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy. Medicine. 75:1996;171-184.
68. sα gene. Proc Natl Acad Sci USA. 95:1998;8715-8720.
69. Wägar G., Lehtivuori J., Salvén I., Backman R., Sivula A. Pseudohypoparathyroidism associated with hypercalcitoninaemia. Acta Endocrinol. 93:1980;43-48.